Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease
- 1 September 1995
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 26 (3) , 469-474
- https://doi.org/10.1016/0272-6386(95)90493-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Formal Analytical Solution to a Regional Blood Flow and Diffusion Based Urea Kinetic ModelAsaio Journal, 1994
- Pharmacotherapeutic Consequences of Recent Advances in Hemodialysis TherapyAnnals of Pharmacotherapy, 1994
- Vancomycin redistribution: Dosing recommendations following highflux hemodialysisKidney International, 1994
- Vancomycin Elimination During High-Flux Hemodialysis: Kinetic Model and Comparison of Four MembranesAmerican Journal of Kidney Diseases, 1992
- Removal of vancomycin by high-flux hemodialysis membranesAntimicrobial Agents and Chemotherapy, 1992
- Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzersKidney International, 1989
- Dosage guidelines for the use of vancomycin based on its pharmacokinetics in infantsEuropean Journal of Clinical Pharmacology, 1988
- Problems in Designing Hemodialysis Drug StudiesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1985
- Pharmacokinetics of vancomycin in patients with various degrees of renal functionAntimicrobial Agents and Chemotherapy, 1984
- Clinical pharmacology and efficacy of vancomycin in pediatric patientsThe Journal of Pediatrics, 1980